Cell u lar and plasma 
The biological changes behind various forms of primary open-angle glaucoma (POAG) are largely unknown. The extracellular matrix of the trabecular meshwork, however, is a likely site for the increased outflow resistance responsible for intraocular hypertension.
MINNA VESALUOMA, pAIVI MERTANIEMI, SARI MANNON EN, ILKKA LEHTO, RISTO UUSITALO, SEPPO SARNA, AHTI TARKKANEN, TIMO TERVO Deposits of exfoliative material may further block the aqueous outflow channels in the trabecular meshwork, resulting in elevation of intraocular pressure and exfoliative glaucoma (EXFG).
Several glycoproteins and proteoglycans have been encountered in the extracellular matrix of the trabecular meshwork. Extracellular matrix components such as fibronectin (FN)/, 2 tenascin,3A thrombospondin, 5 laminin and various collagen types, 2 as well as elastin, 6 , 7 have been identified in the outflow drainage system. The pOSSible role of each protein in the regulation of outflow resistance or development of POAG is not clear. It has also been shown that the aqueous humour of patients with POAG is capable of inducing increased collagen synthesis} which may have a role in the pathogenesis of POAG.
FN is an adhesive extracellular glycoprotein; plasma FN (pFN) is produced in liver, 9 and the cellular form (cFN) is produced locally in developing or regenerating tissues.lQ,ll An extradomain A (EDA) sequence is contained in cFN and distinguishes it from pFN.lO Deposits of FN detected in the inner wall of Schlemm's canal and the juxta canalicular or cribriform parts of the trabecular meshwork seem to increase with age, and apparently correlate with the progression of POAG.1 2 Cultured trabecular meshwork cells have been shown to be capable of secreting all major extracellular matrix constituents of the trabecular meshwork, including FN.13 Tenascin, another extracellular matrix glycoprotein, is present during embryogenesis and in diverse malignant tumours, suggesting that it has a modulatory role in cell growth and tissue remodelling.14,1 5 Tenascin is also expressed during corneal wound healing1 6 ,1 7 and, unlike FN, has been shown to be present only in the inner and outer walls of Schlemm's cana1. 4
Calcitonin gene-related peptide (CGRP) is a neuropeptide of 37 amino acids that has been localised to sensory neurons, including those in the anterior segment of the eye. IS Several animal studies have been conducted to clarify the effects of intracameral CGRP on intraocular pressure. I 9 -2 4 To our knowledge, there are no human studies concerning the occurrence of CGRP in the aqueous humour or its role in the regulation of intraocular pressure.
Kim et al. 25 have reported that glaucoma patients have significantly higher aqueous humour FN concentrations than cataract patients. Our aim was to elucidate whether FN in aqueous humour is cFN or pFN. The tenascin levels were measured because of the similarity of tenascin to FN in the expression or response to various stimuli. Furthermore, as a potential compound affecting intraocular pressure, CGRP concentrations were also investigated.
Materials and methods

Patients
Altogether 68 eyes of white Finnish patients (48 women and 20 men; mean age of 71.9, SD 10.2 years, range 46-92 years) were included in this study. The research followed the tenets of the Declaration of Helsinki. Group 1 included patients with EXFG (11 = 26; mean age 75.3, SD 8.5 years, range 60-92 years), group 2 patients with POAG (11 = 29; mean age 69.4, SD 10.8 years, range 46-85 years) and group 3 patients with senile cataract (11 = 13; mean age 70.5, SD 10.9 years, range 49-84 years). None of the patients in group 3 had glaucoma. All but 2 of the glaucoma patients had been on topical timolol maleate, adrenaline and/ or pilocarpine eye drops and/ or oral medication (acetazolamide). The three groups did not differ from each other in age. The use of long-term glaucoma drugs is shown in Table 1 . The two glaucoma subgroups showed no differences in their pre-operative medication.
The aqueous humour samples were obtained during ocular surgery (extracapsular cataract extraction or trabeculectomy). All patients received 0.5% chloramphenicol (Oftan Akvakol, Leiras, Finland) drops six times daily in both eyes for 3 days before surgery. Drops containing 1% dexamethasone alcohol with neomycin sulphate and polymyxine B sulphate (Maxitrol, Alcon, Puurs, Belgium) and 0.1 % diclofenac sodium (Naclof, Ciba Vision, Hettlingen, Switzerland) were applied four times on the day preceding surgery and once the morning before the operation. Those patients scheduled for an extracapsular cataract Table 1 . The use of antiglaucoma medication in diff erent patient groups
Diagnosis
Beta-blocker Adrenaline extraction were dilated with 1% cyclopentolate hydrochloride (Oftan Syklo, Leiras, Finland) and 10% phenylephrine solutions (Oftan Metaoksedrin, Leiras, Finland) three times and with one drop 0.25% scopolaminehydrobromide (Oftan Scopolamin, Leiras, Finland) before the operation. The glaucoma patients with cataract received additionally 1% apraclonidine (Iopidine, Alcon, TX) drops twice on the pre-operative day and once on the day of surgery. A needle was placed through the cornea into the anterior chamber at the limbus after a superior rectus bridle suture had been put in place to stabilise the globe and the intraocular pressure had been measured with a Schiotz tonometer. After aspiration of 50-100 I.Ll of aqueous humour with the 30 gauge needle, the sample was transferred to an Eppendorf centrifuge tube, stored at -70°C and thawed just before the assay. All other surgical manoeuvres were performed after the aqueous sample was withdrawn.
Enzyme immunoassays for EDAcFN, pFN, tenascin and
CGRP
The concentrations of EDA-containing cFN (EDAcFN), tenascin and CGRP in aqueous humour samples were measured using the enzyme immunoassay (EIA) described in earlier communications; 26 -28 for pFN a similar assay was developed. For overnight coating of 96 well microtitration strips (High binding, Biohit Oy, Helsinki, Finland), 100 I.Ll of monoclonal antibodies (DH1 in EDAcFN, DB7 in tenascin, and 159AC1 in CGRP EIA, respectively) or polyclonal rabbit anti-human fibronectin antibodies (Dakopatts, Glostrup, Denmark) in pFN EIA was used and the wells washed four times with 0.02 M phosphate-buffered saline (PBS), pH 7.0, containing 0.1% Tween 20 prior to use. One hundred microlitres of samples (1:10) were added and incubated for 1 h at 37°C. The unbound material was removed by washing four times with 0.02 M PBS, and horseradish peroxidase (HRP)-conjugated specific monoclonal antibodies (BF12 in EDAcFN, EB2 in tenascin, and CD8 in CGRP EIA, respectively) or polyclonal HRP-conjugated rabbit anti human fibronectin antibodies (Dakopatts, Glostrup, Denmark) in pFN EIA were added.
After incubation for 1 ha t 37°C the strips were washed, and the bound enzyme activity was visualised by the addition of 100 fLl of substrate solution containing H 2 0 2 and tetramethylbenzidine (TMB; Merck, Darmstadt, Germany). Colour formation was allowed to proceed for 30 min, after which 100 fLl of 4 M H 2 S0 4 was added. The absorbances were measured in an Anthos No statistically significant differences could be observed between the two glaucoma subgroups. EXFG, exfoliative glaucoma; POAG, primary open-angle glaucoma. aData from one patient are missing. 
Results
Plasma fibronectin in aqueous humour
About 87% of the total FN in the aqueous humour was due to the presence of pFN. The median pFN and cFN levels of different patient groups are presented in Table 2 .
The pFN levels of patients with EXFG, POAG or cataract were compared (p = 0.0004; Table 3 ). In multiple comparisons EXFG patients showed significantly higher pFN levels than cataract patients (p < 0.01) or POAG patients (p < 0.05). The pFN levels in the latter two groups were not statistically different from each other.
Cellular fibronectin in aqueous humour
When the cFN levels of the three groups were compared, p was 0.0110 (Table 3 ). In multiple comparisons EXFG patients showed significantly higher cFN levels than cataract patients (p < 0.05) or POAG patients (p < 0.05). There was no statistical difference between cFN levels in POAG and cataract patients.
Tenascin and CGRP in aqueous humour
Neither tenascin nor CGRP was detected in the aqueous humour of any of our patients.
Discussion
The present study is in accordance with the finding of Kim et al. 2 5 showing that the aqueous humour FN concentration of glaucoma patients is higher than that of cataract patients. Since exfoliation is not mentioned in this study, we included two types of glaucoma patients in our study: those with primary open-angle glaucoma (POAG) and those with exfoliative glaucoma (EXFG). Our study further shows that it is the EXFG that is responsible for the difference in pFN concentration between glaucoma and control patients. Our results would be even more meaningful if the number of the patients in the cataract group had been closer to that of the glaucoma groups.
The higher levels of pFN in EXFG suggest the presence of a deficiency of the blood-aqueous barrier. This is supported by earlier data indicating that the aqueous protein concentration is significantly higher in eyes with exfoliation than in eyes with cataract or in eyes of POAG patients? 9 The rupture in the blood-aqueous barrier for IgG and albumin in eyes with exfoliation and glaucoma has also been verified.3 D We observed higher pFN and cFN levels in EXFG than in cataract and, furthermore, higher pFN and cFN levels in EXFG than in POAG. Not only does the blood-aqueous barrier seem to be more permeable in EXFG than in cataract or POAG, but also local production of cFN may be more pronounced in EXFG. The pre-operative drugs of the glaucoma and cataract groups were not identical, and this may have influenced our results. The pre-operative medication of the two glaucoma subgroups, on the other hand, was identical. Thus the differences in FN concentrations cannot be explained by damage to the blood-aqueous barrier caused by the pre-operative medication. It is worth mentioning that both cFN and pFN are components of disordered extracellular matrix of exfoliation material. 31 Since it is an adhesive glycoprotein with binding sites for multiple molecules,3 2 FN may have a role in the pathogenesis of exfoliative glaucoma. It is present in all parts of the normal aqueous drainage channels. 46 The altered balance between synthesis and degradation of the extracellular matrix in trabecular meshwork may be involved in the pathogenesis of glaucoma. Furthermore, proteolytic enzymes have been suggested to facilitate infiltration of exfoliative material and development of zonular fragility in exfoliative eyes. 47 Tenascin is present in tear fluid,4 8 but was not found in the aqueous humour of any patient groups. It does not seem to be a component of the aqueous humour. CGRP was unexpectedly not found in any of the samples despite the low detection limit of our assay allowing its demonstration in tears.Z 8 One explanation might be the presence of proteases in the aqueous humour, which might cleave CGRP into non-immunoreactive fragments. Further studies are needed to determine the role of naturally released CGRP in the control of intraocular pressure or modulation of glaucoma pathogenesis in humans.
